Colleen Corey

Colleen Corey discloses dealings in Bio-Rad Laboratories, Inc. to SEC (Form 4). Between 1 September 2023 and 6 September 2025, the trades on record add up to 5 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The newest entry dates from 9 September 2025: a share grant of €53k, in Bio-Rad Laboratories, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.